Physician profile
Eugenio Rodriguez
NPI 1508921172
$178,672.36
in general payments reported to CMS, 2019-2025
38 companies · $48K in 2025
The $48K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $891 · 2020: $308 · 2021: $4,067 · 2022: $4,398 · 2023: $957 · 2024: $120K · 2025: $48K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $166K · Food and Beverage: $2,155 · Travel and Lodging: $480 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $166,352.50 |
| Food and Beverage | $2,155.28 |
| Travel and Lodging | $480.20 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $166,352.50 | 2024-2025 | |
| Tela Bio, INC. | $3,853.49 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Triad Life Sciences INC. | $3,490.78 | 2021-2022 | |
| Musculoskeletal Transplant Foundation INC. | $1,280.61 | 2019-2024 | |
| Aroa Biosurgery Incorporated | $831.68 | 2022-2023 | |
| Kerecis Limited | $341.17 | 2021-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Surgiclose |
| Depuy Synthes Sales INC. | $260.48 | 2019-2025 | Na |
| Integra Lifesciences Corporation | $242.55 | 2019-2023 | Integra, Omnigraft, Surgimend |
| Davol INC. | $191.23 | 2023 | Phasix Mesh |
| Next Science LLC | $176.62 | 2023-2024 | Blastx, Xperience, Surgx |
| Kci USA, INC. | $154.82 | 2020-2023 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Zimmer Biomet Holdings, INC. | $154.04 | 2019-2021 | |
| Smith+Nephew, INC. | $144.61 | 2019-2025 | Oasis, Stravix, Grafix Pl |
| Centinel Spine, LLC | $138.20 | 2022 | |
| Solventum Corporation | $131.02 | 2024 | 3m Coban, 3m Cavilon, Activ.A.C. |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medela LLC | $122.49 | 2019 | |
| Abbvie INC. | $113.03 | 2021-2022 | |
| Intuitive Surgical, INC. | $98.74 | 2022 | |
| Polynovo North America LLC | $57.99 | 2022-2025 | Novosorb Btm |
| Alfasigma USA, INC. | $56.57 | 2021-2022 | |
| Si-Bone, INC. | $49.15 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $48.90 | 2019-2020 | |
| Innocoll Pharmaceuticals Limited | $42.12 | 2021-2022 | |
| Heron Therapeutics, INC. | $39.21 | 2025 | Aponvie |
| Organogenesis INC. | $36.41 | 2021-2024 | |
| Misonix INC | $34.75 | 2021 | |
| Olympus America INC. | $28.48 | 2023 | Olympus |
| Tetraphase Pharmaceuticals, INC. | $24.99 | 2020 | |
| Urgo Medical North America, LLC | $23.77 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Melinta Therapeutics, LLC | $23.14 | 2019 | |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Medtronic, INC. | $19.84 | 2021 | |
| Checkpoint Surgical, INC | $19.35 | 2021 | |
| Bioventus LLC | $14.82 | 2022 | |
| Reprise Biomedical, INC. | $14.65 | 2024 | Miro3d |
| Allergan, INC. | $14.10 | 2020 | |
| Acera Surgical, INC. | $13.53 | 2022 | |
| Thd America, INC. | $12.53 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugenio Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.